Reuters Walgreens' potential deal for drug distributor AmerisourceBergen will boost its cash flow and push it deeper into a lucrative specialty pharmacy market, but may fail to keep it competitive in an evolving U.S. healthcare sector, .ysts said. AmerisourceBergen shares ..ysts say Walgreens possible acquisition of AmerisourceBergen could enhance Walgreens cash flow and enable it to more deeply enter the specialty pharmacy market..Amerisource deal may not keep Walgreens competitive .ysts. Amerisource deal may not keep Walgreens competitive .ysts. Published on .Providers should not expect to see lower drug prices from a potential Walgreens Boots Alliance and AmerisourceBergen Corp. deal, .ysts say. Walgreens would be better off consolidating market share in its core pharmacy business, thereby securing a competitive edge over CVS, RBC Capital wrote..
Related posts to Amerisource deal may not keep Walgreens competitive: analysts
Find the latest business news on Wall Street, jobs and the economy, the housing market, personal finance and money investments and much more on ABC News.
David Harrell is the editor of the Morningstar StockInvestor, a monthly newsletter that focuses on a wide moat stock investing strategy..
Walgreens Boots Alliance, Inc. will provide a live webcast of its annual meeting of stockholders beginning at a.m. MST on Wednesday, ..
French healthcare group Sanofi has agreed to buy U.S. haemophilia specialist Bioverativ for $. billion, its biggest deal for seven years and a major play to .